Results 201 to 210 of about 13,156 (215)

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Lancet, The, 2004
Dean M Wingerchuk, Sean J Pittock, Ichiro Nakashima   +2 more
exaly  

A new era for neuromyelitis optica spectrum disorder

Lancet, The, 2019
Elizabeth Silbermann, Dennis Bourdette
exaly  

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2013
Su-Hyun Kim, So-Young Huh
exaly  

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2017
Chun-Sheng Yang, Fu-Dong Shi
exaly  

Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea

Multiple Sclerosis Journal, 2020
Ho Jin Kim, Sung-Min Kim
exaly  

Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2014
So-Young Huh, Su-Hyun Kim, Jae-Won Hyun
exaly  

Epidemiology of neuromyelitis optica spectrum disorder

Acta Neurologica Scandinavica, 2018
N. Asgari, S. T. Lillevang, H. P. B. Skejoe, M. Falah, E. Stenager, K. O. Kyvik   +5 more
openaire   +3 more sources

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea

Multiple Sclerosis Journal, 2017
Jin Myoung Seok, Suk-Won Ahn, Eun Bin Cho   +2 more
exaly  

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies

JAMA Neurology, 2014
Patrick Waters, Wilhelm Kuker, Angela Vincent   +2 more
exaly  

Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

Multiple Sclerosis Journal, 2012
Su-Hyun Kim, Woojun Kim
exaly